Back to Agenda
Session 6: Global Perspectives: Impact of Biosimilars Around the World – What Have we Learned so Far?
Session Chair(s)
Mauricio Ede, MD, PHD
Chief Medical & Scientific Officer, Sandoz Canada Inc., Canada
Hillel P Cohen, PHD
Biosimilars Expert, Retired, United States
The Biosimilar “Wave” has arrived in the US, but they have been around for quite some time elsewhere. Join us to learn more about international perspectives and insights on implementation, market uptake and the impact on healthcare systems in Europe, Canada, and Latin America, and how these experiences may influence the US.
Learning Objective : At the conclusion of this session, participants should be able to: - Identify best practices developed in foreign markets
- Assess the applicability of insights to the US Marketplace
- Devise plans for implementation while leveraging clinical experience obtained in markets similar to the US
Speaker(s)
Fabrício Oliveira
Head of Biologic Products and Advanced Therapy Medicinal Products Office, ANVISA, Brazil
Speaker
Dustin Loomes, MD
Clinical Assistant Professor; Director, Vancouver Island IBD Clinic, UBC, Canada
Speaker
Merete Lund Hetland, MD, PHD
Consultant in Rheumatology, Professor, DANBIO and University of Copenhagen, Denmark
Speaker
Thiago Mares Guia, MD, PHD
Executive Vice President, Bionovis, Brazil
Speaker
Have an account?